Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87982407 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Jonathan A. Hyman |
Attorney Docket Number | TTCRP.092T |
Law Office Assigned | L90 |
Employee Name | STRUCK, ROBERT J |
2017-07-19 | Application Filed |
2019-11-15 | Status: Live/Pending |
2019-12-18 | Location: DIVISIONAL UNIT |
2019-12-20 | Transaction Date |
Owner: | ![]() |
Address | 2040 Main Street Suite 225 Irvine NV 92614 |
Legal Entity Type | Corporation |
Legal Entity State | NV |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Goods permitted by the Farm Bill and not subject to the FDCA: Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hemp oils or extracts and CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing CBD derived from industrial hemp extracted solely from the mature stalks and sterilized seeds with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Pharmaceutical preparations, namely, herbal sprays and oils containing cannabidiol (CBD) derived from industrial hemp in whole or significant part for relief of aches, pains, and anxiety with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Balms for medical purposes containing cannabidiol oil and CBD derived from industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain containing cannabidiol oil and CBD derived from industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Balms for medical purposes containing industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain containing industrial hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Balms for medical purposes containing CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain containing CBD with a delta-9 THC concentration of not more than 0.3% on a dry weight basis |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-07-22 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-07-26 | 2 NWOS I:Incoming Correspondence |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2017-07-25 | 3 PARI I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2017-08-01 | 4 DOCK D:Assigned to Examiner |
ASSIGNED TO LIE | 2017-08-17 | 5 ALIE A:Allowance for Publication |
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2017-08-23 | 6 AMPX O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2017-11-07 | 7 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-11-14 | 8 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-11-14 | 9 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-11-14 | 10 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-05-14 | 11 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-05-14 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-05-15 | 13 TEME I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2018-06-02 | 14 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2018-06-02 | 15 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2018-06-02 | 16 GNS3 O:Outgoing Correspondence |
ASSIGNED TO LIE | 2019-01-14 | 17 ALIE A:Allowance for Publication |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2019-01-15 | 18 RCCK S: |
NON-FINAL ACTION WRITTEN | 2019-05-14 | 19 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2019-05-14 | 20 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-05-14 | 21 GNRN O:Outgoing Correspondence |
TEAS REQUEST TO DIVIDE RECEIVED | 2019-11-14 | 22 ERTD I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-11-14 | 23 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-11-14 | 24 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-11-15 | 25 TEME I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-12-16 | 26 AITU A:Allowance for Publication |
DIVISIONAL REQUEST RECEIVED | 2019-11-14 | 27 DRRR I:Incoming Correspondence |
DIVISIONAL PROCESSING COMPLETE | 2019-12-18 | 28 DPCC D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2020-02-25 | 29 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2020-02-25 | 30 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-02-25 | 31 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-08-25 | 32 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-08-25 | 33 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-08-26 | 34 TEME I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2020-09-17 | 35 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2020-09-17 | 36 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-09-17 | 37 GNRN O:Outgoing Correspondence |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2021-03-31 | 38 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2021-04-01 | 39 MAB2 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.